Cancer Therapy News and Research

RSS

Tiny medical device containing gold specks could boost effects of cancer drugs

A tiny medical device containing gold specks could boost the effects of cancer medication and reduce its harm, research suggests.

7 Aug 2017

Researchers reveal potential of radiomics to improve precision medicine

Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules.

3 Aug 2017

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet today (Wednesday).

3 Aug 2017

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization, recognized contributions to the field of nuclear medicine and molecular imaging during its 2017 Annual Meeting in Denver, Colorado. Several awards ceremonies were held to recognize the valuable role SNMMI members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Researchers ferreting out patients most likely to become resistant to cancer treatment

According to the National Cancer Institute, the number of people beating a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024. Now, that's good news, but it doesn't mean that cancer researchers - in the lab or clinic - are resting on any laurels.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

Penn researchers discover how DNA damage turns immune cells against cancer

Cancer is essentially a disease of the cell replication cycle. The goal of treating the disease is to permanently kill off the cells that replicate with abandon without any molecular brakes.

31 Jul 2017

New law in Rhode Island mandates fertility preservation coverage prior to medical treatment

Rhode Island has become the first state to pass a law explicitly requiring coverage for fertility preservation prior to gonadotoxic medical therapy, treatment that could directly or indirectly cause infertility.

31 Jul 2017

Stem cell-based method selectively targets cancerous tissue while preventing toxic side effects

A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a more localized way.

27 Jul 2017

Research offers explanation for ineffectiveness of checkpoint immunotherapy against bladder cancer

New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

25 Jul 2017

New genomic research partnership promises to redefine and transform cancer treatment

Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System's Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx.

21 Jul 2017

Researchers devise strategy to target Achilles heel of nervous system cancers

Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment.

21 Jul 2017

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Understanding the mechanisms that give cancer cells the ability to survive and grow opens the possibility of developing improved treatments to control or cure the disease.

19 Jul 2017

Researchers uncover new mechanism that promotes growth of blood vessels in tumors

Cancer cells have an enormous need for oxygen and nutrients. Therefore, growing tumors rely on the simultaneous growth of capillaries, the fine branching blood vessels that form a supply network for them.

18 Jul 2017

UK behind other European countries in cancer care, report says

A new report published today, which was commissioned by The Association of the British Pharmaceutical Industry, shows that in cancer treatment, the UK trails behind the rest of the Euro

18 Jul 2017

Study finds low rate of breast cancer recurrence after nipple-sparing mastectomy

Women with breast cancer who undergo nipple-sparing mastectomy (NSM) have a low rate of cancer returning within the first five years when most recurrences in the breast are diagnosed, findings of a single-center study show.

18 Jul 2017

New analysis compares emerging algorithms that look for cancer mutations

Sanford Burnham Prebys Medical Discovery Institute has undertaken the first-ever comparative analysis of a newly emerging category of algorithms that mine genetic information in cancer databases by focusing on internal gene structure (subgene resolution algorithms), in contrast to classical approaches that focus on genes treated as single units.

17 Jul 2017

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.

17 Jul 2017

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels.

14 Jul 2017

Cancer Therapy News and Research

Tiny medical device containing gold specks could boost effects of cancer drugs

Researchers reveal potential of radiomics to improve precision medicine

Breast cancer patients treated with targeted radiotherapy experience fewer side effects

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Researchers ferreting out patients most likely to become resistant to cancer treatment

Shaping the future of oncology treatment

Penn researchers discover how DNA damage turns immune cells against cancer

New law in Rhode Island mandates fertility preservation coverage prior to medical treatment

Stem cell-based method selectively targets cancerous tissue while preventing toxic side effects

Research offers explanation for ineffectiveness of checkpoint immunotherapy against bladder cancer

New genomic research partnership promises to redefine and transform cancer treatment

Researchers devise strategy to target Achilles heel of nervous system cancers

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Researchers uncover new mechanism that promotes growth of blood vessels in tumors

UK behind other European countries in cancer care, report says

Study finds low rate of breast cancer recurrence after nipple-sparing mastectomy

New analysis compares emerging algorithms that look for cancer mutations

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News